Like a weather forecast predicting rain and temperature, experts are figuring out how to issue predictions for sharky waters.

Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of new additions to its  R&D Systems™ AI-Engineered ...

Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

Brii Biosciences (Brii Bio) has reported topline end-of-treatment (EOT) data from its ongoing Phase IIb ENRICH and ENHANCE trials assessing sequential and concurrent use of BRII-179, elebsiran, and ...

Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.

Biomedical engineer Sangeeta Bhatia reflects on her journey in pioneering liver research, developing advanced diagnostics, ...